Twitter
YouTube
Linkedin
Facebook
Email
ABOUT
Company
Leadership
Investors
Laboratory
Careers
PRODUCTS
IMMUNO-ONCOLOGY
ACE ImmunoID Platform
NeoantigenID
ImmunogenomicsID
ONCOLOGY RESEARCH
ACE Extended Cancer Panel for DNA
ACE Extended Cancer Panel for RNA
ACE Cancer Research Exome
ACE Cancer Research Transcriptome
ONCOLOGY DIAGNOSTICS
ACE CancerPlus Test
SOLUTIONS
Personalized Cancer Vaccines
Biomarker Discovery Solutions
TECHNOLOGY
Our Processes
Unlock the power of DNA
Optimizing RNA
NeoantigenID
MHC binding prediction
ImmunogenomicsID
Reliable delivery
NEWS
Press Releases
In the News
Events
Library
Blog
CONTACT
Press Releases
Request Info
Press Releases
mckinleymedia
2018-02-23T16:14:12+00:00
16
Apr, 2018
Jennifer Havlek
2018-04-16T05:01:28+00:00
Personalis, Inc. to Present New Data at the American Association for Cancer Research (AACR) Annual Meeting 2018
8
Feb, 2018
Jennifer Havlek
2018-02-08T05:29:49+00:00
Personalis, Inc. Releases the Latest Version of NeoantigenID™ for Enhanced Neoantigen Identification on the ACE ImmunoID™ Platform
6
Feb, 2018
Jennifer Havlek
2018-02-06T08:48:13+00:00
Personalis, Inc. Launches ImmunogenomicsID™ for Multidimensional Immuno-Oncology Biomarker Analysis as the Latest Enhancement to the ACE ImmunoID™ Platform
30
Nov, 2017
Jennifer Havlek
2017-12-13T15:05:36+00:00
Personalis Awarded New Contract with the US Department of Veterans Affairs to Provide Clinical Cancer Genomic Testing and Analysis for the Precision Oncology Program
16
Nov, 2017
mckinleymedia
2017-12-13T15:12:38+00:00
Personalis, Inc. Launches Early Access Program for Cell-Free DNA ACE Exome for Tumor Neoantigens
14
Nov, 2017
Jennifer Havlek
2017-12-13T15:15:02+00:00
Dr. Richard Chen, Chief Scientific Officer, Personalis, Inc. to Present Data and Discuss Tumor Immuno-genomics and Personalized Vaccines Solutions at 2017 Neoantigen Summit
7
Nov, 2017
Jennifer Havlek
2017-12-13T15:18:45+00:00
Personalis Wins New Contract to Sequence >34,000 Whole Human Genomes for the VA’s Million Veteran Program
24
Apr, 2017
mckinleymedia
2017-12-13T15:21:22+00:00
Personalis, Inc. Receives Approval from the New York State Department of Health for Clinical Tests Based on the ACE Exome
20
Apr, 2017
mckinleymedia
2017-12-13T15:23:02+00:00
Personalis Inc. Orders Ten Illumina NovaSeq™ 6000 Systems for Immuno-Oncology Genomics and Large-Scale Whole Genome Sequencing
1
Dec, 2016
mckinleymedia
2017-12-13T15:26:24+00:00
Parker Institute for Cancer Immunotherapy and Cancer Research Institute Launch Collaboration on Cancer Neoantigens
15
Nov, 2016
mckinleymedia
2017-12-13T15:34:20+00:00
Personalis Launches Report Providing In-Depth Characterization of Tumor Neoantigen Peptides
13
Oct, 2016
mckinleymedia
2017-12-13T15:39:00+00:00
Personalis Announces Scaling Sequencing Capacity, Information Systems and Operations to Support Immuno-Oncology Clinical Trials for 2017
6
Oct, 2016
mckinleymedia
2017-12-12T16:40:02+00:00
Personalis Awarded US Department of Veterans Affairs Contract for Whole Genome Sequencing and Data Analysis for the Million Veteran Program
8
Oct, 2015
mckinleymedia
2017-12-13T15:50:45+00:00
Personalis Launches ACE ImmunoID NGS Services for Immuno-Oncology
19
Mar, 2015
mckinleymedia
2017-12-13T15:45:17+00:00
Personalis Awarded US Department of Veterans Affairs Contract for Clinical Cancer Genomic Testing and Research Analysis
13
Jan, 2015
mckinleymedia
2017-12-13T15:56:02+00:00
Personalis Raises $33M in Series C Financing
20
Oct, 2014
mckinleymedia
2017-12-12T17:46:41+00:00
Personalis Introduces New Services for Cancer Research and Clinical Trials
15
Oct, 2014
mckinleymedia
2017-12-12T17:47:57+00:00
Personalis to Showcase New Products for Cancer Research and Inherited Disease Testing at ASHG Annual Meeting
23
Apr, 2014
mckinleymedia
2017-12-13T07:08:16+00:00
Personalis, Inc. Receives Accreditation from College of American Pathologists (CAP)
26
Mar, 2014
mckinleymedia
2017-12-12T17:40:07+00:00
ACE Clinical Exome™ Test Enhances Diagnostic Yield; Personalis to Present Results of 2nd Generation Augmented Exome at ACMG
21
Oct, 2013
mckinleymedia
2017-12-13T16:12:20+00:00
Personalis Launches the ACE Clinical Exome™
7
Oct, 2013
mckinleymedia
2017-12-13T15:59:40+00:00
Personalis Closes $22M Series B Financing
30
Jun, 2013
mckinleymedia
2018-01-06T14:06:11+00:00
Personalis Co-Founder Dr. Atul Butte MD, Stanford University, Recognized at the White House
7
May, 2013
mckinleymedia
2017-12-13T07:09:38+00:00
Personalis Announces Illumina CSPro Certification for Sequencing
30
Apr, 2013
mckinleymedia
2017-12-13T16:41:51+00:00
Michael Fitzpatrick joins Personalis as Vice President Worldwide Sales
Archive
